Attached files

file filename
S-1/A - AMENDMENT NO. 3 TO FORM S-1 - ARGOS THERAPEUTICS INCd214145ds1a.htm
EX-10.10 - FORM OF NONSTATUTORY STOCK OPTION AGREEMENT - ARGOS THERAPEUTICS INCd214145dex1010.htm
EX-10.8 - 2011 STOCK INCENTIVE PLAN - ARGOS THERAPEUTICS INCd214145dex108.htm
EX-10.28 - 2011 EMPLOYEE STOCK PURCHASE PLAN - ARGOS THERAPEUTICS INCd214145dex1028.htm
EX-10.9 - FORM OF INCENTIVE STOCK OPTION AGREEMENT - ARGOS THERAPEUTICS INCd214145dex109.htm
EX-3.2 - RESTATED CERTIFICATE OF INCORPORATION - ARGOS THERAPEUTICS INCd214145dex32.htm
EX-3.4 - AMENDED AND RESTATED BYLAWS - ARGOS THERAPEUTICS INCd214145dex34.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Registration Statement on Form S-1/A of Argos Therapeutics, Inc. of our report dated July 29, 2011 relating to the financial statements, which appears in such Registration Statement. We also consent to the references to us under the heading “Experts” in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

Raleigh, North Carolina

January 6, 2012